Cardiovascular Clinical Studies
Clinical Trials
To learn about participating in clinical trials, ask your cardiovascular specialist. Learn more about the leading-edge Cottage Health Research Institute (CHRI).
Connect With CHRI
For the past 15 years, cardiovascular clinicians have been conducting research at Cottage. More than 30 unique clinical trials have brought innovative technology, life-saving devices and expanded medication choice to Cottage patients that wouldn’t otherwise be available. The treatment options from these clinical trials will continue to enhance existing medical services provided to patients by Cottage clinician researchers.
Cardiovascular research at Cottage Health covers a spectrum of investigation and encompasses the different areas of cardiovascular expertise of our health care providers. Our research extends to investigational clinical trials (phases III-IV), registries, and retrospective studies. CH conducts industry-sponsored trials as well as investigator-initiated studies.
The Cottage Health Research Institute (CHRI) is an integral part of Cottage Health. For more than 20 years, CHRI has offered consultation, liaison, and administrative resources to researchers to support the translation of clinical and academic research. CHRI works closely with investigators to implement protocols at Cottage Health and assists in participant screening, consenting, enrolling, conducting study visits, and collection and entry of data.
Participation in clinical trials allows Cottage Health to offer the best possible range of treatment options and access to cutting-edge treatments for patients in our own community.
TCT Conference in San Francisco
Nationally Recognized Research
Dr. Joseph Aragon and the Cottage Structural Heart team presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.
The Transcatheter Cardiovascular Therapeutics conference is one of the world’s largest and most influential educational meetings specializing in interventional cardiovascular medicine.